Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The employee awards cover stock options and restricted stock units, with four-year vesting tied to continued service.

Rhea-AI Summary

Vera Therapeutics (Nasdaq: VERA) granted equity inducement awards to three new employees on November 2, 2026, under its 2024 Inducement Plan.

The awards comprise options to purchase 14,900 Class A shares at $30.25 per share, matching the closing trading price on the grant date, and restricted stock units (RSUs) covering 7,450 Class A shares. Options vest over four years: 25% on the first anniversary of the applicable vesting commencement date, followed by monthly vesting over 36 months. RSUs vest 25% on each anniversary of November 20, 2026. Both schedules require continued service through the applicable vesting dates.

Positive

• None.

Negative

• Minor point. Forward-looking: it has not happened yet and may not happen.Options for 14,900 Class A shares at $30.25 per share create potential dilution.
• Minor point. Forward-looking: it has not happened yet and may not happen.RSUs covering 7,450 Class A shares create potential dilution as they vest.

Key Figures

Stock options: 14,900 shares Restricted stock units: 7,450 shares Option exercise price: $30.25 per share +3 more

Stock options

14,900 shares

Inducement awards to new employees

Restricted stock units

7,450 shares

Inducement awards to new employees

Option exercise price

$30.25 per share

Equal to the closing trading price on the grant date

Recipients

3 new employees

Inducement awards

Option vesting

4 years

25% on the first anniversary; balance monthly over 36 months

RSU vesting

4 years

25% on each anniversary

Historical Context

1 past event · Latest: Oct 02

1 event

1. Oct 02

   Inducement grants

   24h Move

   -1.9%

   Prior cohort received options and RSUs under the same plan, with four-year vesting.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

non-qualified stock options, restricted stock units

2 terms

non-qualified stock options financial

"inducement awards consisting of non-qualified stock options to purchase 14,900 shares"

Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.

restricted stock units financial

"and restricted stock units (RSUs) underlying 7,450 shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRISBANE, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on November 2, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 14,900 shares of Class A common stock and restricted stock units (RSUs) underlying 7,450 shares of Class A common stock to three (3) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).

Each stock option granted on November 2, 2026 has an exercise price per share equal to $30.25, Vera Therapeutics’ closing trading price on November 2, 2026. Each stock option will vest over four years, with 25% of the underlying shares vesting on the first anniversary of the applicable vesting commencement date and the balance of the underlying shares vesting monthly thereafter over 36 months, subject to the new employee’s continued service relationship with Vera Therapeutics through the applicable vesting dates. Each of the RSU awards will vest over four years, with 25% of the underlying shares vesting on each anniversary of November 20, 2026, subject to the new employee’s continued service relationship with Vera Therapeutics through the applicable vesting dates. The awards are subject to the terms and conditions of the Inducement Plan and the terms and conditions of an applicable award agreement covering the grant.

About Vera Therapeutics
Vera Therapeutics is a commercial-stage biotechnology company focused on the pursuit of truth in science to transform medicine in autoimmune disease, starting with the kidney. Vera Therapeutics’ flagship commercial product is TRUTAKNA^® (atacicept-vymj), a B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL) inhibitor. Vera Therapeutics is evaluating multiple diseases where the reduction of autoantibodies through inhibition of BAFF and APRIL may prove clinically meaningful. Vera Therapeutics was founded in 2016 and is based in Brisbane, California. To learn more, visit www.veratx.com.

For more information, please contact:

Investor Contact:
Joshua Qin
Vera Therapeutics
650-360-6978
ir@veratx.com

Media Contact:
Debra Charlesworth
Vera Therapeutics
415-854-8051
corporatecommunications@veratx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What inducement awards did Vera Therapeutics grant to new employees?

Vera Therapeutics granted three new employees options to purchase 14,900 Class A shares and RSUs covering 7,450 Class A shares on November 2, 2026. The options have a $30.25 exercise price per share, equal to the closing trading price that day.

When do Vera Therapeutics' November 2026 inducement awards vest?

Both award types vest over four years, subject to continued service. Options vest 25% on the first anniversary of the applicable vesting commencement date, with the balance vesting monthly over 36 months. RSUs vest 25% on each anniversary of November 20, 2026.